Drugs / Modified Process Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00441012 | Dec 2006 → Jun 2008 | haemophilus infectious disease, hepatitis B virus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified Process Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00441012 ↗ |
| Modality | Vaccine | “a combination hepatitis B and Haemophilus influenzae B vaccine (mpHBV-Hib).” PMID 21875633 ↗ Aug 2011 |